O​pen funding, investment and M&A opportunities​


 

Govtech and Medtech and data models | Ref: 0725

  • Funding required:  150k € private funding, 10% anual interest, returned to investors within 6 months.
  • Sector of activity:  this company is maturing a artificial intelligence platform for optimal managing of human migration and mobility.
  • Other details:  the platform is already functional and seeking to broaden services in an increasing number of countries within Europe and EMEA regions.

Edtech and Medtech | Ref: 0625

  • Funding required: Currently seeking a combination of non-dilutive financing and convertible notes.
  • Sector of activity: Med-tech and Ed-tech.
  • Other details: Following the close of a €1M pre-seed round, the Founders retain over 80% equity. Team: We have 10+ full-time staff and highly engaged top-tier advisors, some of whom have already invested. Location: Headquartered in Spain. Locations in Navarra, Barcelona and Madrid. Business Model: Highly scalable, accessible product with a large TAM (Total Addressable Market). Applicable globally to healthcare students/professionals (B2C) and clinics, hospitals & universities (B2B).

Novel device for Alzheimer, Parkinson and neurodegeneration | Ref: 0525

  • Funding required: 100k-300k eur Investment Opportunity: Medical Device for Neurodegenerative Diseases.
  • Sector of activity: Funding sought to develop a medical device enhancing efficacy & safety of therapies for Alzheimer’s, Parkinson’s & related conditions.
  • Other details: Now entering human clinical trials. Early-stage investors can participate via a convertible loan note.

Novel therapies with IA | Ref: 0425

  • Funding required: 5,5M€ Series A round, in two parts: 2M€ in 2025 and 3,5M€ in 2026. Bridge round of up to 400k € in discounted convertible notes available until end of August 2025. Funds will cover preclinical development and manufacturing expenses required to advance the lead candidate to clinical trials in humans.
  • Sector of activity: Medtech. Novel therapeutic products designed with support of cutting-edge IA tools. Innovative therapeutic approach with AI-designed compounds. Efficacy data in animal models already available. Return: anticipated 20x+ multiplier at exit for investors in this 2025 round. Exit planned for 2030.
  • Other details: solid scientific foundation team, clear development roadmap and long-term vision. Global market, projected to surpass $44B by 2032.

Chemical engineering and green hydrogen | Ref: 0325

  • Funding required: 750k €. Funds will cover cash flow for the development, there is a minimum viable product previously developed in collaboration with a Technology Center.
  • Sector of activity: Medtech and Edtech. Investment Opportunity in Chemical Engineering Project: Efficient Hydrolysis and Green Hydrogen Generation.
  • Other details: 10% return per annum on invested capital (from investment date), structured as debt with an option to convert into equity upon proven profitability. Guarantee: Established company with a solid track record and diversified operations. Holds a granted subsidy amounting to 2.8M €.

Health and Artificial Intelligence | Ref: 0225

  • Funding required: 150k €
  • Sector of activity: Medtech and Edtech. Investment Opportunity in Health-tech & artificial intelligence. Innovative company with strong project portfolio and growth potential.
  • Other details: 10% return per annum on invested capital (from investment date). Guarantee: Company holds a pending VAT refund (reimbursement expected before end of July).

 

Visual aid for optometrists and low-vision patients | Ref: 0125

  • Funding required: 650k €.
  • Sector of activity: Medtech and Edtech. Investment Opportunity in Health-tech. Investment will cover international marketing and expansion.
  • Other details: 10% return per annum on invested capital (from investment date). 


Contact us